Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma: Clinical Trail

NCT06150144 is registered in ClinicalTrials.gov with University of Aleppo as lead sponsor.

NCT NCT06150144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma: Clinical Trail
Lead sponsor
University of Aleppo
Phase
Phase 3
Overall status
Unknown status
Start date
May 25, 2023
Completion date
May 25, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, bcc